Sanofi reports strong Q3 results, driven by record Dupixent sales and pipeline progress, despite vaccine headwinds.
Young Blue Jays pitcher Yesavage dominates Dodgers, putting Toronto on the brink of a World Series title.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Sanofi reports strong Q3 results, driven by record Dupixent sales and pipeline progress, despite vaccine headwinds.
Young Blue Jays pitcher Yesavage dominates Dodgers, putting Toronto on the brink of a World Series title.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.